Paul Brannelly
CIK 1394936 · Executive Vice President & CFO · last filed 2021-02-12
Paul Brannelly is an Executive Vice President & CFO who has filed 37 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing shows the insider had shares withheld for taxes covering $220.3K of COLL on Feb 12, 2021. Across all open-market trades the lifetime net is −$352.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ESPR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2 MERCER ROAD
NATICK, MA 01760
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COLL | Executive Vice President & CFO | 215,428 | $24.91 | $5.37M | $0 | 11 | 2021-02-12 |
| COLLEGIUM PHARMACEUTICAL, INC (ESPR) Delisted | Executive Vice President & CFO | 151,387 | $3.18 | $481.4K | -$187.4K | 19 | 2019-08-13 |
| KPTI | SVP, FIN & ADMIN, SEC & TRES | — | $0.04 | — | $0 | 1 | 2013-12-20 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | VP Finance, Treasurer | 31,643 | — | — | -$165.0K | 6 | 2008-05-30 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-12 | COLL | Tax (F) | −8,491 | -$220.3K | EDGAR |
| 2021-01-22 | COLL | Grant (A) | +50,161 | $0 | EDGAR |
| 2021-01-21 | COLL | Grant (A) | +50,161 | $0 | EDGAR |
| 2020-08-12 | COLL | Tax (F) | −1,515 | -$28.6K | EDGAR |
| 2020-02-12 | COLL | Tax (F) | −4,025 | -$87.0K | EDGAR |
| 2020-02-07 | COLL | Grant (A) | +28,125 | $0 | EDGAR |
| 2020-01-22 | COLL | Tax (F) | −214 | -$4.6K | EDGAR |
| 2019-08-13 | COLLEGIUM PHARMACEUTICAL, INC (ESPR) Delisted | Mixed | −720 | -$9.8K | EDGAR |
| 2019-07-23 | COLLEGIUM PHARMACEUTICAL, INC (ESPR) Delisted | Tax (F) | −181 | -$1.9K | EDGAR |
| 2019-02-11 | COLLEGIUM PHARMACEUTICAL, INC (ESPR) Delisted | Tax (F) | −2,693 | -$38.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.